Emery VC - Search Results

1

Could a vaccine against immune-evading cytomegalovirus become a reality?

Emery VC. Emery VC. Expert Rev Vaccines. 2011 Aug;10(8):1109-11. doi: 10.1586/erv.11.92. Expert Rev Vaccines. 2011. PMID: 21854303 No abstract available.

2

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.

Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O'Beirne J, Thorburn D, Patch D, Atkinson CE, Pichon S, Sweny P, Lanzman M, Woodford E, Rothwell E, Old N, Kinyanjui R, Haque T, Atabani S, Luck S, Prideaux S, Milne RS, Emery VC, Burroughs AK. Griffiths PD, et al. Among authors: emery vc. Lancet. 2011 Apr 9;377(9773):1256-63. doi: 10.1016/S0140-6736(11)60136-0. Lancet. 2011. PMID: 21481708 Free PMC article. Clinical Trial.

3

Cytomegalovirus and the aging population.

Emery VC. Emery VC. Drugs Aging. 2001;18(12):927-33. doi: 10.2165/00002512-200118120-00004. Drugs Aging. 2001. PMID: 11888347 Review.

4

Response to letter regarding "cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy".

Atabani SF, Emery VC, Smith C, Harber M, Thorburn D, Griffiths PD. Atabani SF, et al. Among authors: emery vc. Am J Transplant. 2012 Oct;12(10):2859-60. doi: 10.1111/j.1600-6143.2012.04227.x. Am J Transplant. 2012. PMID: 23009144 Free article. No abstract available.

5

Cytomegalovirus: recent progress in understanding pathogenesis and control.

Emery VC. Emery VC. QJM. 2012 May;105(5):401-5. doi: 10.1093/qjmed/hcr262. Epub 2011 Dec 22. QJM. 2012. PMID: 22198913 Free PMC article. Review.

6

Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency.

Marashi SM, Raeiszadeh M, Enright V, Tahami F, Workman S, Chee R, Webster AD, Milne RS, Emery VC. Marashi SM, et al. Among authors: emery vc. J Allergy Clin Immunol. 2012 May;129(5):1349-1356.e3. doi: 10.1016/j.jaci.2012.02.011. Epub 2012 Mar 22. J Allergy Clin Immunol. 2012. PMID: 22444511

7

Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy.

Deayton JR, Prof Sabin CA, Johnson MA, Emery VC, Wilson P, Griffiths PD. Deayton JR, et al. Among authors: emery vc. Lancet. 2004 Jun 26;363(9427):2116-21. doi: 10.1016/S0140-6736(04)16500-8. Lancet. 2004. PMID: 15220032

8

Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy.

Buyck HC, Griffiths PD, Emery VC. Buyck HC, et al. Among authors: emery vc. J Clin Virol. 2010 Sep;49(1):32-6. doi: 10.1016/j.jcv.2010.06.018. Epub 2010 Jul 27. J Clin Virol. 2010. PMID: 20667769

9

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.

Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Emery VC, et al. Lancet. 2000 Jun 10;355(9220):2032-6. doi: 10.1016/S0140-6736(00)02350-3. Lancet. 2000. PMID: 10885354

10

Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy.

Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Perálvarez M, Rolando N, Harber M, Jones G, O'Riordan A, Burroughs AK, Thorburn D, O'Beirne J, Milne RS, Emery VC, Griffiths PD. Atabani SF, et al. Among authors: emery vc. Am J Transplant. 2012 Sep;12(9):2457-64. doi: 10.1111/j.1600-6143.2012.04087.x. Epub 2012 May 17. Am J Transplant. 2012. PMID: 22594993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page